1. Home
  2. TCBP

TCBP

TC BioPharm (Holdings) plc

Logo TC BioPharm (Holdings) plc

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-16-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform.

Founded: 2013 Country:
United Kingdom
United Kingdom
Employees: N/A City: HOLYTOWN
Market Cap: 4.3M IPO Year: 2022
Target Price: $1400.00 AVG Volume (30 days): 4.7M
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -23.91 EPS Growth: N/A
52 Week Low/High: $0.85 - $440.00 Next Earning Date: 04-30-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: